Ibio: Relating To The Private Placement Is Hereby Incorporated By Reference Into This Item 3.02. Based In Part Upon The Representations Of The Investors In The Purchase Agreement, The Offering And Sale Of The Shares Was Made In Reliance On The Exemption Afforded By Regulation D Under The Securities Act, And Corresponding Provisions Of State Securities Or “blue Sky” Laws. The Shares Have Not Been Registered Under The Securities Act Or Any State Securities Laws And May Not Be Offered Or Sold In The United States Absent Registration With The Securities And Exchange Commission Or An Applicable Exemption From The Registration Requirements. The Sale Of The Shares Did Not Involve A Public Offering And Was Made Without General Solicitation Or General Advertising. Each Of The Investors Represented That They Are An Accredited Investor, As Such Term Is Defined In Rule 501(a) Of Regulation D Under The Securities Act, And That They Are Acquiring The Shares For Investment Purposes Only And Not With A View To Any Resale, Distribution Or Other Disposition Of The Shares In Violation Of The U.s. Federal Securities Laws

Show full article

This functionality is available for registred users only

• Full name
  Ibio Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***